Pharmaceutical industry marketing: understanding its impact on women's health

Obstetrical & Gynecological Survey
Carolyn B Sufrin, Joseph S Ross

Abstract

The delivery of modern health care entails significant involvement from the pharmaceutical industry, including developing and manufacturing drugs. However, the industry also has tremendous influence on the practice of medicine through its considerable marketing efforts, both to patients through direct to consumer advertising, and to physicians through detailing, providing samples, continuing medical education, and other efforts. This article will review the role that pharmaceutical marketing plays in health care, and the substantial evidence surrounding its influence on patient and physician behaviors, with additional discussion of the medical device industry, all with particular attention to women's health. Understanding the effects of pharmaceutical marketing on women's health, through discussion of relevant examples-including oral contraceptive pills, drugs for premenstrual dysphoric disorder, Pap smear cytology techniques, and neonatal herpes prophylaxis-will help ensure that women receive unbiased, evidenced-based care. We will conclude with a discussion of guidelines that have been proposed by professional organizations, policy makers, and universities, to assist physicians in managing exposure to pharmaceutical marketing.

References

Jul 1, 1982·The American Journal of Medicine·J AvornR Hartley
Apr 26, 1995·JAMA : the Journal of the American Medical Association·M G ZieglerB C Singer
Apr 1, 1994·Archives of Family Medicine·R Levy
Apr 16, 1998·Journal of General Internal Medicine·R V GibbonsK Kroenke
Jul 24, 1998·JAMA : the Journal of the American Medical Association·A FlanaginD Rennie
Jan 27, 2000·JAMA : the Journal of the American Medical Association·A Wazana
Jun 22, 2000·The New England Journal of Medicine·M Angell
Nov 1, 2000·JAMA : the Journal of the American Medical Association·A J Huang
Sep 18, 2001·JAMA : the Journal of the American Medical Association·S K SigworthG M Cohen
Feb 15, 2002·The New England Journal of Medicine·Sidney M Wolfe
Apr 16, 2002·BMJ : British Medical Journal·Ray MoynihanDavid Henry
May 31, 2003·BMJ : British Medical Journal·Joel LexchinOtavio Clark
Oct 15, 2003·Archives of Internal Medicine·Allan S BrettJamaluddin Moloo
Nov 5, 2003·The American Journal of Bioethics : AJOB·John J Paris
Nov 5, 2003·The American Journal of Bioethics : AJOB·Dana KatzJon F Merz
Nov 5, 2003·The American Journal of Bioethics : AJOB·Allan S Brett
Nov 5, 2003·The American Journal of Bioethics : AJOB·Howard Brody
Dec 20, 2003·BMJ : British Medical Journal·Lynn Eaton
Feb 14, 2004·The Journal of the American Board of Family Practice·Elizabeth MurrayKen Lee
Oct 8, 2004·The New England Journal of Medicine·Eric J Topol
Jan 28, 2005·The New England Journal of Medicine·Ernst R Berndt
Feb 8, 2005·American Journal of Obstetrics and Gynecology·Mona SaintGeorge F Sawaya
Feb 11, 2005·The New England Journal of Medicine·Robert Steinbrook
Apr 28, 2005·JAMA : the Journal of the American Medical Association·Richard L KravitzPeter Franks
Aug 9, 2005·The American Journal of Medicine·Richard F Adair, Leah R Holmgren
Sep 24, 2005·Medical Care Research and Review : MCRR·Michele M SpenceMirta Millares
Oct 4, 2005·Obstetrics and Gynecology·Zane A BrownLawrence Corey
Dec 6, 2005·American Journal of Obstetrics and Gynecology·Carolyn GardellaLawrence Corey
Dec 24, 2005·Contraception·Johannes Huber, Katharina Walch
Jan 26, 2006·JAMA : the Journal of the American Medical Association·Troyen A BrennanNeil Smelser
Apr 7, 2006·PLoS Medicine·Ray Moynihan, David Henry
Jun 27, 2006·Academic Medicine : Journal of the Association of American Medical Colleges·John A SchneiderHolly Humphrey
Oct 3, 2006·Journal of Medical Ethics·M A MorganJ Schulkin
Jan 20, 2007·BMJ : British Medical Journal·Harlan M KrumholzDavid S Egilman
Jan 30, 2007·Perspectives in Biology and Medicine·Barton Moffatt, Carl Elliott
Jan 31, 2007·Annals of Family Medicine·Dominick L FroschFrances K Barg
Mar 22, 2007·JAMA : the Journal of the American Medical Association·Joseph S RossHarlan M Krumholz
Apr 26, 2007·PLoS Medicine·Michael A SteinmanLisa A Bero
Apr 27, 2007·The New England Journal of Medicine·Eric G CampbellDavid Blumenthal

❮ Previous
Next ❯

Citations

Jun 23, 2010·Archives of Surgery·Deborah KorensteinJoseph S Ross
Aug 2, 2011·European Journal of Clinical Pharmacology·Christoph L LassenChristoph H R Wiese
Apr 24, 2012·American Journal of Obstetrics and Gynecology·David L EisenbergJeffrey F Peipert
Aug 8, 2014·British Journal of Clinical Pharmacology·Israel Rico-Alba, Albert Figueras

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.